Log In
Print
BCIQ
Print
Print this Print this
 

DuoCort, Plenadren (hydrocortisone tablet)

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionOnce-daily dual-release hydrocortisone tablet
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAdrenal insufficiency
Indication DetailsTreat Addison's disease; Treat adrenal insufficiency
Regulatory Designation

U.S. - Orphan Drug (Treat adrenal insufficiency);
EU - Orphan Drug (Treat adrenal insufficiency);
Switzerland - Orphan Drug (Treat Addison's disease)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today